Irfan Peksoy
Irfan Peksoy has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Aysun Uroglu Unal
Department of Neurology, Zonguldak Karaelmas University Faculty of Medicine, Zonguldak, Turkey
1 shared publication- Ayşe Esra ARSLAN
Erzurum Bölge Eğitim ve Araştırma Hastanesi
1 shared publication - Ebru Salmanoğlu
ADANA ŞEHİR HASTANESİ
1 shared publication - Ishak Ozel Tekin
Department of Immunology
1 shared publication - Rıza Şefizade
Sağlık Bilimleri Üniversitesi Ankara Bilkent Şehir Hastanesi
1 shared publication - Selim Aydemir
Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 1087-1094
Evaluation of Oncologic Patients with Suspected Lesions on Planar Bone Scintigraphy Using SPECT/CT
Aim: This study aimed to evaluate the diagnostic accuracy of SPECT/CT to clinical management in oncologic patients with indeterminate lesions on planar bone scintigraphy. Methods: A total of 1170 oncologic patients who underwent planar bone scintigraphy between March 2010 and September 2012 were retrospectively reviewed. Benign and malignant lesions could be differentiated on planar bone scintigraphy in 670 patients, whereas the remaining 500 patients with indeterminate findings were included in the study. The final diagnosis was established by clinical follow-up, diagnostic CT, MRI, F-18 FDG PET/CT, biopsy, or a combination of these reference standard methods.Results: Of the 500 patients included in the study, 261 were male and 239 were female, with a mean age of 59.5±14.3 years. Based on SPECT/CT findings, 306 patients (61.2%) were classified as benign, 129 (25.8%) as malignant, and 65 (13.0%) as indeterminate. Of the 306 patients classified as benign on SPECT/CT, 4 (0.8%) were subsequently confirmed to have bone metastases, whereas 4 (0.8%) of the 129 patients classified as malignant were ultimately diagnosed as benign. Of the 65 patients with indeterminate SPECT/CT findings, 21 (4.2%) were confirmed to have malignant lesions, whereas 44 (8.8%) were found to have benign lesions. The sensitivity, specificity, PPV, NPV, and overall diagnostic accuracy of SPECT/CT were 97.3%, 86.3%, 75.3%, 98.7%, and 89.6%, respectively (p
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 1087-1094
Open AccessEvaluation of Oncologic Patients with Suspected Lesions on Planar Bone Scintigraphy Using SPECT/CT
Aim: This study aimed to evaluate the diagnostic accuracy of SPECT/CT to clinical management in oncologic patients with indeterminate lesions on planar bone scintigraphy. Methods: A total of 1170 oncologic patients who underwent planar bone scintigraphy between March 2010 and September 2012 were retrospectively reviewed. Benign and malignant lesions could be differentiated on planar bone scintigraphy in 670 patients, whereas the remaining 500 patients with indeterminate findings were included in the study. The final diagnosis was established by clinical follow-up, diagnostic CT, MRI, F-18 FDG PET/CT, biopsy, or a combination of these reference standard methods.Results: Of the 500 patients included in the study, 261 were male and 239 were female, with a mean age of 59.5±14.3 years. Based on SPECT/CT findings, 306 patients (61.2%) were classified as benign, 129 (25.8%) as malignant, and 65 (13.0%) as indeterminate. Of the 306 patients classified as benign on SPECT/CT, 4 (0.8%) were subsequently confirmed to have bone metastases, whereas 4 (0.8%) of the 129 patients classified as malignant were ultimately diagnosed as benign. Of the 65 patients with indeterminate SPECT/CT findings, 21 (4.2%) were confirmed to have malignant lesions, whereas 44 (8.8%) were found to have benign lesions. The sensitivity, specificity, PPV, NPV, and overall diagnostic accuracy of SPECT/CT were 97.3%, 86.3%, 75.3%, 98.7%, and 89.6%, respectively (p
- 5 December 2023
- Published by Kayseri City Education and Research Hospital in Journal of Anatolian Medical Research
- Vol. 8 (4) , 54-59
MPS’de SPECT/BT ve EKG-Gated ile Atenüasyon Düzeltmeli̇ Görüntüleri̇n Eklenmesi̇ Hangi̇ Hasta Grubu İçi̇n Faydalıdır?
Özet Amaç: Miyokard perfüzyon sintigrafisinde (MPS) meme dokusu ve diyafragma atenüasyonu gibi yanlış pozitifliğe neden olan çok sayıda neden vardır. Çalışmamızda MPS’de rest görüntülemeye çağırmada, Tek foton komputerize tomografi/Bilgisayarlı tomografi (SPECT/BT) ve elektrokardiyografi (EKG) gated Tek foton komputerize tomografi (SPECT)’yi etkileyen faktörlerin katkısını araştırmak istedik. Hastalar ve Yöntemler: Şubat 2012 ve Mayıs 2013 tarihleri arasında MPS SPECT/BT yapılan ve normal çalışma olarak yorumlanan 258 hasta çalışmaya dahil edildi. Stres atenüasyon düzeltmeli (AD), attenüasyon düzeltmeli olmayan (NAD) ve EKG gated SPECT görüntüleri ayrı ayrı analiz edildi ve rest MPS gerekip gerekmediğine karar verildi. Vücut kitle indeksi (VKİ), yaş ve cinsiyet arasındaki ilişki değerlendirildi. Bulgular: 258 hastanın 127'sinde (%49,2) rest MPS ihtiyacı olduğu saptandı. MPS görüntülerini SPECT/BT ile yorumladığımızda bu oran %11,2'ye düştü. SPECT/BT’ye EKG-gated SPECT görüntüleri eklendiğinde bu oranın %6,6'ya düşmekte olduğu ve bu görüntülerin VKİ <35kg m² olan hasta grubunda en büyük katkıyı sağladığı görüldü. Sonuç: SPECT/BT ve EKG gated ile MPS'nin özellikle VKİ<35 kg/m² olan hastalar için faydalı olacağını düşünüyoruz.
- 5 December 2023
- Published by Kayseri City Education and Research Hospital in Journal of Anatolian Medical Research
- Vol. 8 (4) , 54-59
MPS’de SPECT/BT ve EKG-Gated ile Atenüasyon Düzeltmeli̇ Görüntüleri̇n Eklenmesi̇ Hangi̇ Hasta Grubu İçi̇n Faydalıdır?
Özet Amaç: Miyokard perfüzyon sintigrafisinde (MPS) meme dokusu ve diyafragma atenüasyonu gibi yanlış pozitifliğe neden olan çok sayıda neden vardır. Çalışmamızda MPS’de rest görüntülemeye çağırmada, Tek foton komputerize tomografi/Bilgisayarlı tomografi (SPECT/BT) ve elektrokardiyografi (EKG) gated Tek foton komputerize tomografi (SPECT)’yi etkileyen faktörlerin katkısını araştırmak istedik. Hastalar ve Yöntemler: Şubat 2012 ve Mayıs 2013 tarihleri arasında MPS SPECT/BT yapılan ve normal çalışma olarak yorumlanan 258 hasta çalışmaya dahil edildi. Stres atenüasyon düzeltmeli (AD), attenüasyon düzeltmeli olmayan (NAD) ve EKG gated SPECT görüntüleri ayrı ayrı analiz edildi ve rest MPS gerekip gerekmediğine karar verildi. Vücut kitle indeksi (VKİ), yaş ve cinsiyet arasındaki ilişki değerlendirildi. Bulgular: 258 hastanın 127'sinde (%49,2) rest MPS ihtiyacı olduğu saptandı. MPS görüntülerini SPECT/BT ile yorumladığımızda bu oran %11,2'ye düştü. SPECT/BT’ye EKG-gated SPECT görüntüleri eklendiğinde bu oranın %6,6'ya düşmekte olduğu ve bu görüntülerin VKİ <35kg m² olan hasta grubunda en büyük katkıyı sağladığı görüldü. Sonuç: SPECT/BT ve EKG gated ile MPS'nin özellikle VKİ<35 kg/m² olan hastalar için faydalı olacağını düşünüyoruz.
- 1 December 2005
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 20 (4) , 235-238
Fulminant hepatic failure associated with propylthiouracil: A case report with treatment emphasis on the use of plasmapheresis
Propylthiouracil is a commonly used medication for hyperthyroidism. Though propylthiouracil‐induced hepatotoxicity is a rarely encountered problem, death due to fulminant hepatic failure may occur. In the English literature, only 34 cases have been described with severe hepatotoxicity secondary to this drug. Here we report a case of fulminant hepatic failure due to propylthiouracil and review the issues of treatment and management with special emphasis on the use of plasmapheresis in such situations. J Clin Apheresis 2005.
- 1 December 2005
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 20 (4) , 235-238
Fulminant hepatic failure associated with propylthiouracil: A case report with treatment emphasis on the use of plasmapheresis
Propylthiouracil is a commonly used medication for hyperthyroidism. Though propylthiouracil‐induced hepatotoxicity is a rarely encountered problem, death due to fulminant hepatic failure may occur. In the English literature, only 34 cases have been described with severe hepatotoxicity secondary to this drug. Here we report a case of fulminant hepatic failure due to propylthiouracil and review the issues of treatment and management with special emphasis on the use of plasmapheresis in such situations. J Clin Apheresis 2005.